Relmada Therapeutics, Inc. (RLMD)
7.58
+0.20
(+2.71%)
USD |
NASDAQ |
Apr 14, 11:11
Relmada Therapeutics Cash from Investing (TTM) : -48.14M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| Theravance Biopharma, Inc. | -105.28M |
| Avalo Therapeutics, Inc. | -81.72M |
| AN2 Therapeutics, Inc. | 28.31M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |